I think for you to not be perplexed at the quality of management to find a complete contra indicator of what was “found” in a post hoc analysis on the P2 trial speaks volumes for verbal and critical reasoning.
I don’t see much rebuttal on my post that, according to Mesoblast’s market announcements since 2009 “everything is awesome”. Nice to see rampers stick up for management that hypes and sensationalises their company for over a decade and has not got a single run on the board.
USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse, page-56
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.078M | 1.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 299536 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 138397 | 28 |
View Market Depth
| Last trade - 15.02pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |